GW Pharmaceuticals (GW Pharmaceuticals) Change In Inventory : $-38.9 Mil (TTM As of Mar. 2021)

View and export this data going back to . Start your Free Trial

What is GW Pharmaceuticals Change In Inventory?

GW Pharmaceuticals's change in inventory for the quarter that ended in Mar. 2021 was $-7.9 Mil. It means GW Pharmaceuticals's inventory increased by $7.9 Mil from Dec. 2020 to Mar. 2021 .

GW Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2020 was $-39.9 Mil. It means GW Pharmaceuticals's inventory increased by $39.9 Mil from Dec. 2019 to Dec. 2020 .

GW Pharmaceuticals's Total Inventories for the quarter that ended in Mar. 2021 was $137.6 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. GW Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2021 was 1,030.84.

Inventory Turnover measures how fast the company turns over its inventory within a year. GW Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2021 was 0.09.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GW Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2021 was 0.87.

GW Pharmaceuticals Change In Inventory Historical Data

The historical data trend for GW Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GW Pharmaceuticals Change In Inventory Chart

GW Pharmaceuticals Annual Data

Trend

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Dec19

Dec20

Change In Inventory

Get a 7-Day Free Trial

0.66

0.01

-13.65

-51.13

-39.87

GW Pharmaceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Change In Inventory	Get a 7-Day Free Trial															-8.93	-10.74	-11.52	-8.69	-7.91

GW Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-38.9 Mil.

GW Pharmaceuticals (OTCPK:GWPRF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GW Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	133.3825	/	11.807	*	365 / 4
	=	1,030.84

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

GW Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	11.807	/	133.3825
	=	0.09

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GW Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	133.3825	/	152.466
	=	0.87

GW Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of GW Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

GW Pharmaceuticals (GW Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GW Pharmaceuticals PLC (OTCPK:GWPRF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sovereign House, Chivers Way, Vision Park, Histon, Cambridge, GBR, CB24 9BZ

Website

http://www.gwpharm.com

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.